Merger Notification - Announcement according to § 10 Cartel Act
Goldman Sachs Group, Inc.; Aragen Life Sciences Private Limited
BWB/Z-5348
On 02.04.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
long with funds managed by them, intend to acquire up to 31.1% of the equity shares (with strategic veto rights) in Aragen Life Sciences Private Limited, India.
Field of business concerned: Research and development on biotechnology
Industry sector: M - Erbringung von freiberuflichen, wissenschaftlichen und technischen Dienstleistungen
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 30.04.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 01.05.2021 .